Trevena, Inc. Profile Avatar - Palmy Investing

Trevena, Inc.

Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein bi…

Biotechnology
US, Chesterbrook [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Trevena, Inc. has no acquisition track records yet.

M&A Deals · History

Trevena, Inc. has no acquisition track records yet.

End of TRVN's Analysis
CIK: 1429560 CUSIP: 89532E109 ISIN: US89532E2081 LEI: - UEI: -
Secondary Listings
TRVN has no secondary listings inside our databases.